ValiRx(VAL)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE AIM All-Share

Market Cap

£2.91m

Change Today

0.000p

Share Price

5.50p

ValiRx surges on joint venture news

Date: Tuesday 11 Dec 2007

LONDON (ShareCast) - Shares in AIM-listed cancer treatment company ValiRx jumped by 17% after it announced a joint venture with Belgium’s Institute of Pathology and Genetics (IPG).

The joint venture will create ValiBIO, a research and commercialisation company.

ValiBIO will receive funding and staff from BIO, the commercial arm of the IPG, and will be used to develop technologies that ValiRx holds licenses for.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

ValiRx Market Data

Currency UK Pounds
Share Price 5.50p  
Change Today 0.000p
52 Week High 20.00
52 Week Low 4.88
Volume 521
Shares Issued 53.00m
Market Cap £2.91m
Beta 0.25
RiskGrade 255

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
17.83% below the market average17.83% below the market average17.83% below the market average17.83% below the market average17.83% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Price Trend
63.62% below the market average63.62% below the market average63.62% below the market average63.62% below the market average63.62% below the market average
41.57% below the sector average41.57% below the sector average41.57% below the sector average41.57% below the sector average41.57% below the sector average
Income Not Available
Growth
29.26% below the market average29.26% below the market average29.26% below the market average29.26% below the market average29.26% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average
Price Chg 6m
58.32% below the market average58.32% below the market average58.32% below the market average58.32% below the market average58.32% below the market average
32.58% below the sector average32.58% below the sector average32.58% below the sector average32.58% below the sector average32.58% below the sector average
P/E Not Available
PEG Not Available
Dividend Yield Not Available
EPS Growth Not Available
Operating Margin
95.03% below the market average95.03% below the market average95.03% below the market average95.03% below the market average95.03% below the market average
52.63% below the sector average52.63% below the sector average52.63% below the sector average52.63% below the sector average52.63% below the sector average

ValiRx Dividends

No dividends found

Trades for 05-Sep-2008

Time Volume / Share Price
10:57 521 @ 5.45p

ValiRx Key Personnel

CEO Satu Vainikka

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).